News & Articles 18/10/2023 Our Network Soliris approved in China for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) Approval exemplifies commitment to broadening access for patients living with rare diseases globally.
News & Articles 26/06/2023 Our Network Soliris recommended for approval in the EU by CHMP for children and adolescents with refractory generalised myasthenia gravis (gMG) Potential approval for Soliris would mark first and only targeted treatment for this patient population in the European Union.
